Novo Nordisk sues Eli Lilly over ads comparing GLP-1 medications

By /


The Danish company Novo says U.S.-based Lilly isn’t including the most up-to-date clinical information about its drugs.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top